- Home
- BBAI vs ELVN Comparison
BBAI vs ELVN Comparison
Compare BBAI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBAI | ELVN |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 4.2B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BBAI | ELVN |
|---|---|---|
| Price | $2.89 | $48.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.50 | ★ $43.40 |
| AVG Volume (30 Days) | ★ 14.1M | 974.8K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.43 | 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $127,672,000.00 | N/A |
| Revenue This Year | $13.89 | N/A |
| Revenue Next Year | $11.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.59 | $14.79 |
| 52 Week High | $9.39 | $62.32 |
Technical Indicators
Market Signals| Indicator | BBAI | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 25.79 |
| Support Level | $2.59 | $25.63 |
| Resistance Level | $3.28 | $52.39 |
| Average True Range (ATR) | 0.11 | 2.20 |
| MACD | -0.00 | -1.23 |
| Stochastic Oscillator | 48.52 | 5.65 |
Price Performance
Historical ComparisonAbout BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a provider of mission-ready artificial intelligence (AI) technology originally founded to serve defense and national security mission customers. The Company provides Edge AI-powered decision intelligence solutions, including artificial intelligence and machine learning, generative AI, data science, computer vision, biometrics, cyber, cloud solutions, and systems integration. Customers rely on its predictive analytics capabilities in mission-based operating environments. Its solutions are organized into five markets, including Supply Chain & Logistics Solutions, Cybersecurity Solutions, Autonomous Systems Solutions, Digital Identity Services, and the Ask Sage Platform.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.